Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 The waning effect of postmenopausal estrogen therapy on osteoporosis.

× No keyword cloud information.

8 in total

1. Large-scale hormone replacement therapy and life expectancy: results from an international comparison among European and North American populations.

Authors: S Panico; R Galasso; E Celentano; A V Ciardullo; L Frova; R Capocaccia; M Trevisan; F Berrino
Journal: Am J Public Health Date: 2000-09 Impact factor: 9.308

Review 2. The next step after anti-osteoporotic drug discontinuation: an up-to-date review of sequential treatment.

Authors: Núria Guañabens; María Jesús Moro-Álvarez; Enrique Casado; Josep Blanch-Rubió; Carlos Gómez-Alonso; Guillermo Martínez Díaz-Guerra; Javier Del Pino-Montes; Carmen Valero Díaz de Lamadrid; Pilar Peris; Manuel Muñoz-Torres
Journal: Endocrine Date: 2019-04-08 Impact factor: 3.633

Review 3. Prevention. How much harm? How much benefit? 2. Ten potential pitfalls in determining the clinical significance of benefits.

Authors: K G Marshall
Journal: CMAJ Date: 1996-06-15 Impact factor: 8.262

Review 4. Hormone replacement therapy in the aged. A state of the art review.

Authors: S Jacobs; T C Hillard
Journal: Drugs Aging Date: 1996-03 Impact factor: 3.923

Review 5. Hormone replacement therapy: II. A pharmacoeconomic appraisal of its role in the prevention of postmenopausal osteoporosis and ischaemic heart disease.

Authors: R Whittington; D Faulds
Journal: Pharmacoeconomics Date: 1994-06 Impact factor: 4.981

6. Department of Health shoots itself in the hip. Why the report of the Advisory Group on Osteoporosis undermines evidence based purchasing.

Authors: T A Sheldon; A Raffle; I Watt
Journal: BMJ Date: 1996-02-03

7. Bone mineral density measurements: are they worth while?

Authors: D J Torgerson; C Donaldson; D M Reid
Journal: J R Soc Med Date: 1996-08 Impact factor: 18.000

8. Discontinuation of denosumab and associated fracture incidence: analysis from the Fracture Reduction Evaluation of Denosumab in Osteoporosis Every 6 Months (FREEDOM) trial.

Authors: Jacques P Brown; Christian Roux; Ove Törring; Pei-Ran Ho; Jens-Erik Beck Jensen; Nigel Gilchrist; Christopher Recknor; Matt Austin; Andrea Wang; Andreas Grauer; Rachel B Wagman
Journal: J Bone Miner Res Date: 2013-04 Impact factor: 6.741

8 in total